MAP1LC3A and hepatocellular carcinoma: Compared to this group, patients with low LC3 expression in both tissues (−/−; 18.5, 60.0, 94.3, and 100%, respectively), those low LC3 expression in HCC tissues only (−/+; 10.5%, 42.1%, 64.4%, and 76.2%, respectively) and those low LC3 expression in ANT tissues only (+/−; 6.7%, 55.0%, 70.0%, and 100%, respectively) were significantly more prone to HCC recurrence (Fig. 1d).